Glaxo

Federal regulators said they were suspending use of a monoclonal antibody drug known as sotrovimab to treat high-risk Covid-19 patients in the United States because it was unlikely to be effective against the Omicron subvariant known as…

Sanofi and GlaxoSmithKline Plc, the pharma giants that stumbled in the race to develop a Covid-19 shot, found their vaccine protects against severe disease and hospitalization and will submit data to regulators for clearance.…

LONDON — The company behind Advil, ChapStick and Tums is the target of the first big multibillion-dollar takeover fight of 2022.Unilever said on Monday that it remained interested in buying the maker of those products, a joint venture of…

<!-- -->The observations come amid uncertainty over the new Covid variant omicron.GlaxoSmithKline Plc said research shows its Covid-19 antibody treatment is effective against the full combination of mutations in the new omicron…